These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 694229)

  • 1. Effect of platelet count and hematocrit on the coagulability of heparinized blood.
    Ramstack JM; Zuckerman L; Mockros LF; Caprini JA; Vagher JP
    Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):327-42. PubMed ID: 694229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of prostacyclin on the coagulation of whole blood.
    Holloway DS; Zuckerman L; Vagher JP; Mockros LF
    Thromb Haemost; 1983 Oct; 50(3):671-5. PubMed ID: 6359571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
    Dempfle CE; Kälsch T; Elmas E; Suvajac N; Lücke T; Münch E; Borggrefe M
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):765-70. PubMed ID: 19002042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia.
    Lang T; Johanning K; Metzler H; Piepenbrock S; Solomon C; Rahe-Meyer N; Tanaka KA
    Anesth Analg; 2009 Mar; 108(3):751-8. PubMed ID: 19224779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of low-molecular-weight and unfractioned heparin in horses.
    Monreal L; Villatoro AJ; Monreal M; Espada Y; Anglés AM; Ruiz-Gopegui R
    Am J Vet Res; 1995 Oct; 56(10):1281-5. PubMed ID: 8928943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of factors that can modify platelet-rich plasma properties.
    Andrade MG; de Freitas Brandão CJ; Sá CN; de Bittencourt TC; Sadigursky M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e5-e12. PubMed ID: 18155603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model of clot growth as a function of heparin and platelet concentration.
    Ramstack JM; Zuckerman L; Caprini JA; Mockros LF
    Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):157-66. PubMed ID: 905628
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet involvement in the activated coagulation time of heparinized blood.
    Moorehead MT; Westengard JC; Bull BS
    Anesth Analg; 1984 Apr; 63(4):394-8. PubMed ID: 6367544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
    Palatianos GM; Foroulis CN; Vassili MI; Matsouka P; Astras GM; Kantidakis GH; Iliopoulou E; Melissari EN
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the sensitivity of an in vitro high frequency ultrasound device to monitor the coagulation process: study of the effects of heparin treatment in a murine model.
    Callé R; Rochefort GY; Desbuards N; Plag C; Antier D; Ossant F
    Ultrasound Med Biol; 2010 Feb; 36(2):295-305. PubMed ID: 20045589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
    Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
    Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lithium heparin and tripotassium EDTA on hematologic values of Hermann's tortoises (Testudo hermanni).
    Muro J; Cuenca R; Pastor J; Vinas L; Lavin S
    J Zoo Wildl Med; 1998 Mar; 29(1):40-4. PubMed ID: 9638624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin ablates force development during platelet mediated clot retraction.
    Carr ME; Carr SL; Greilich PE
    Thromb Haemost; 1996 Apr; 75(4):674-8. PubMed ID: 8743198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothermia and acidosis synergistically impair coagulation in human whole blood.
    Dirkmann D; Hanke AA; Görlinger K; Peters J
    Anesth Analg; 2008 Jun; 106(6):1627-32. PubMed ID: 18499589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients.
    Brophy DF; Martin EJ; Nolte ME; Kuhn JG; Carr ME
    Haemophilia; 2007 Sep; 13(5):533-41. PubMed ID: 17880440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
    Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
    Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of platelet contractile force as a research and clinical measure of platelet function.
    Carr ME
    Cell Biochem Biophys; 2003; 38(1):55-78. PubMed ID: 12663942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of red blood cells to the saturable mechanism of heparin clearance.
    Young E; Hirsh J
    Thromb Haemost; 1990 Dec; 64(4):559-63. PubMed ID: 2084941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.